Migraine

Hand-held device may relieve migraine pain

08/03/2010 | A hand-held device delivering a magnetic pulse to the back of the head is more effective than sham stimulation for the treatment of migraine with aura, a US study suggests.


Folate stops migraine

24/05/2009 | Queensland researchers say they have produced "compelling evidence" that folate supplements can reduce the frequency and severity of migraine attacks.


Migraines during pregnancy associated with increased vascular risk

20/03/2009 | A study of over 5 million hospital stays has found a strong correlation between active peripartum migraine and vascular diagnoses during pregnancy.


Gene variant affects link between migraine and CVD

19/02/2009 | Women who have the ACE D/I or DD genotypes and experience migraine with aura are at twice the risk of cardiovascular disease than women with migraines without aura, research shows.


Telcagepant: a new option for migraine treatment

08/12/2008 | An oral calcitonin-gene-related peptide receptor antagonist, telcagepant, has been shown to have a similar efficacy in treating migraine as zolmitriptan, but with fewer side-effects. Source:  Ho, T. et al. Lancet 2008; published online.


Migraine doubles VTE risk

26/09/2008 | Migraine is not associated with atherosclerosis but may be a risk factor for coagulation disorders such as venous thromboembolism , new research suggests. Source: Schwaiger, J. et al. Neurology 2008; 71: 937-943.


Migraine patients miss out

17/09/2008 | Migraine patients are missing out on effective preventive treatments because of a reluctance by GPs to try different medications, an Australian neurologist claims.


Early treatment of migraine with sumatriptan/naproxen combination effective

17/07/2008 | A fixed-dose single-tablet formulation of sumatriptan/naproxen taken within an hour after the onset of a migraine is effective in relieving symptoms, a trial shows. Source: Silberstein, S. Neurology 2008; 71:114-121.


Single dose IV dexamathasone significantly reduces migraine recurrence

13/06/2008 | When added to standard abortive therapy for migraine headache, single dose parenteral dexamethasone is associated with a 26% relative reduction in headache recurrence within 72 hours, a meta-analysis of seven randomised controlled trials concludes. Source: Colman, I. et al. British Medical Journal 2008;published online before print, doi:10.1136/bmj.39566.806725.BE BE


Migraine frequency linked with CVD risk

22/04/2008 | Women who have weekly migraine are three times more likely to have a stroke than those with fewer migraines or no migraine at all, an analysis of the Women’s Health Study shows.


More Migraine news

Journals

Members of Neurology Update can access the following journals for free:

Most viewed articles this week

Related sites